FDA Recalls 233,000 Bottles of Duloxetine Over Risk of Cancerous Chemical
The FDA recalled over 233,000 bottles of duloxetine (Cymbalta; Eli Lilly & Company), citing concerns over severe levels of nitrosamine drug substance impurity, N-nitroso-duloxetine, a known carcinogenic chemical. This follows the recall in October 2024 …